GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Hangzhou Tigermed Consulting Co Ltd (SZSE:300347) » Definitions » Gross Profit

Hangzhou Tigermed Consulting Co (SZSE:300347) Gross Profit : ¥2,539 Mil (TTM As of Sep. 2024)


View and export this data going back to 2012. Start your Free Trial

What is Hangzhou Tigermed Consulting Co Gross Profit?

Hangzhou Tigermed Consulting Co's gross profit for the three months ended in Sep. 2024 was ¥637 Mil. Hangzhou Tigermed Consulting Co's gross profit for the trailing twelve months (TTM) ended in Sep. 2024 was ¥2,539 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Hangzhou Tigermed Consulting Co's gross profit for the three months ended in Sep. 2024 was ¥637 Mil. Hangzhou Tigermed Consulting Co's Revenue for the three months ended in Sep. 2024 was ¥1,709 Mil. Therefore, Hangzhou Tigermed Consulting Co's Gross Margin % for the quarter that ended in Sep. 2024 was 37.28%.

Hangzhou Tigermed Consulting Co had a gross margin of 37.28% for the quarter that ended in Sep. 2024 => Competition eroding margins

During the past 13 years, the highest Gross Margin % of Hangzhou Tigermed Consulting Co was 47.43%. The lowest was 37.34%. And the median was 43.33%.

Warning Sign:

Hangzhou Tigermed Consulting Co Ltd gross margin has been in long-term decline. The average rate of decline per year is -3.1%.


Hangzhou Tigermed Consulting Co Gross Profit Historical Data

The historical data trend for Hangzhou Tigermed Consulting Co's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hangzhou Tigermed Consulting Co Gross Profit Chart

Hangzhou Tigermed Consulting Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,302.90 1,514.24 2,270.66 2,808.46 2,848.53

Hangzhou Tigermed Consulting Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 798.47 568.97 628.12 704.92 637.23

Competitive Comparison of Hangzhou Tigermed Consulting Co's Gross Profit

For the Diagnostics & Research subindustry, Hangzhou Tigermed Consulting Co's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hangzhou Tigermed Consulting Co's Gross Profit Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Hangzhou Tigermed Consulting Co's Gross Profit distribution charts can be found below:

* The bar in red indicates where Hangzhou Tigermed Consulting Co's Gross Profit falls into.



Hangzhou Tigermed Consulting Co Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Hangzhou Tigermed Consulting Co's Gross Profit for the fiscal year that ended in Dec. 2023 is calculated as

Gross Profit (A: Dec. 2023 )=Revenue - Cost of Goods Sold
=7384.039 - 4535.51
=2,849

Hangzhou Tigermed Consulting Co's Gross Profit for the quarter that ended in Sep. 2024 is calculated as

Gross Profit (Q: Sep. 2024 )=Revenue - Cost of Goods Sold
=1709.371 - 1072.137
=637

Gross Profit for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥2,539 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Hangzhou Tigermed Consulting Co's Gross Margin % for the quarter that ended in Sep. 2024 is calculated as

Gross Margin % (Q: Sep. 2024 )=Gross Profit (Q: Sep. 2024 ) / Revenue (Q: Sep. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=637 / 1709.371
=37.28 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Hangzhou Tigermed Consulting Co  (SZSE:300347) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Hangzhou Tigermed Consulting Co had a gross margin of 37.28% for the quarter that ended in Sep. 2024 => Competition eroding margins


Hangzhou Tigermed Consulting Co Gross Profit Related Terms

Thank you for viewing the detailed overview of Hangzhou Tigermed Consulting Co's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Hangzhou Tigermed Consulting Co Business Description

Traded in Other Exchanges
Address
Block 8, No. 19 Jugong Road, Room 2001-2010, 20th Floor, Xixing Sub-District, Binjiang District, Hangzhou, CHN, 310053
Hangzhou Tigermed Consulting Co Ltd is a China-based Contract Research Organization. The company's segment includes Clinical trial solutions and Clinical-related and laboratory services. It generates maximum revenue from the Clinical trial solutions segment. The company's offered services include bioanalytical, medical writing, biostatistics analysis, and medical imaging. The therapeutic areas of the company include Infections, Hematology, Cardiovascular, Endocrinology, Rheumatology, Nephrology, and Central Nervous System (CNS) among others.
Executives
Directors, executives
Cao Xiao Chun Directors, executives
Executives
Ye Xiao Ping Director
Shi Xiao Li Supervisors
Wang Xiao Bo Supervisors
Li Xiao Ri Securities Affairs Representative
Xu Jia Lian Executives
Gong Yan Hua Director

Hangzhou Tigermed Consulting Co Headlines

No Headlines